<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03965663</url>
  </required_header>
  <id_info>
    <org_study_id>2238/2017</org_study_id>
    <nct_id>NCT03965663</nct_id>
  </id_info>
  <brief_title>Vibro-tactile Pressure Feedback of the Prosthetic Foot for Trans-tibial Amputees</brief_title>
  <official_title>Vibro-tactile Pressure Feedback of the Prosthetic Foot for Trans-tibial Amputees</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Agnes Sturma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Applied Sciences Upper Austria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the influence of a vibro-tactile device on&#xD;
      trans-tibial amputees in terms of gait, pain and perception of the prosthesis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is divided into three phases. The initial phase lasts 6 to 8 weeks for each&#xD;
      subject. For subjects of group 2 the length of the initial phase depends on the progression&#xD;
      of the re-innervation. The initial phase ends, when the subject can perceive the tactile&#xD;
      stimulate at the re-innervated area of the skin. During the initial phase, all subjects get a&#xD;
      new prosthesis. To minimize the adjusting to the new prosthesis only a new socket, which&#xD;
      houses the vibro-tactile Feedback system, is fabricated and the old prosthetic food is&#xD;
      re-used. After a period of 3 weeks minimum, where the subjects use the new prosthesis, a gait&#xD;
      analysis and an assessment of the sensitivity of the skin at the stump are performed.&#xD;
&#xD;
      Subsequently the intervention phase starts and the vibro-tactile feedback system is&#xD;
      activated. For a period of 6 months the subjects use the new prostheses with the integrated&#xD;
      vibro-tactile feedback system in daily living. After 2 and 4 months, the subjects visit the&#xD;
      study site for an assessment of the sensitivity of the skin. After 6 months a second gait&#xD;
      analysis and an other assessment of the sensitivity of the skin a the stump are performed.&#xD;
      Afterwards the vibro-tactile feedback-system is disabled.&#xD;
&#xD;
      During the observing phase the subjects use the prosthesis with the disabled vibro-tactile&#xD;
      feedback system for 4 months.&#xD;
&#xD;
      During all three phases the subjects answer the questionnaires every 2 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Trinity Amputation and Prosthesis Experience Scales-Revised (TAPES-R)</measure>
    <time_frame>1 year</time_frame>
    <description>The Trinity Amputation and Prosthesis Experience Scales-Revised (TAPES-R) is a multidimensional instrument designed to examine the psychosocial processes involved in adjusting to amputation and a prosthesis. TAPES consists of 9 subscales, with possible scores depending on the single subscale. The range is from 0-12 to 0-25 (depending on the number of items and answer possibilities).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fall Efficacy Scale International Version (FES-I)</measure>
    <time_frame>1 year</time_frame>
    <description>The Fall Efficacy Scale International Version (FES-I) is a questionaire that assesses the fear of falling. Scores can range from 16-64, with a higher score indicating a higher fear of falling.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Visual analoge scale (VAS)</measure>
    <time_frame>1 year</time_frame>
    <description>The pain is measured with a Visual analoge scale form 0 to 10. O indicates no pain, while 10 is the worst pain the person can imagine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of falls within the last two months</measure>
    <time_frame>1 Year</time_frame>
    <description>Subjects report the number a falls within the last two months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait parameters</measure>
    <time_frame>6 months</time_frame>
    <description>Two gait analysis are performed with a 3D video-based marker system. Standard gait parameters (as cardence, speed, step length and weight) as well as kinematic and kinetic parameters are calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>two point discrimination</measure>
    <time_frame>6 months</time_frame>
    <description>the two point discrimination (in mm) at the skin of the stump is assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>touch perception threshold</measure>
    <time_frame>6 months</time_frame>
    <description>the touch percertion at the skin of the stump is assessed with mono filaments</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">13</enrollment>
  <condition>Amputation</condition>
  <arm_group>
    <arm_group_label>Trans-tibial Amputees</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Unilateral Trans-tibial Amputees that use vibro-tactile feedback for six months in daily living</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trans-tibial Amputees with TSR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Unilateral Trans-tibial Amputees that use vibro-tactile feedback for six months in daily living. The subjects underwent a functional nerv-transfer surgery prior to participation, where the proximal part of the sural nerv was to the distal part of the saphenous nerv.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vibro-tactile Feedback</intervention_name>
    <description>The device measures the force between the prosthetic food and the ground. With this signals, vibratators are triggered. The vibrators are housed by the prosthetic socket and stimulate the stump.</description>
    <arm_group_label>Trans-tibial Amputees</arm_group_label>
    <arm_group_label>Trans-tibial Amputees with TSR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  unilateral trans-tibial amputation&#xD;
&#xD;
          -  uses a prostheses already for more than 1 year&#xD;
&#xD;
          -  sufficient touch sensitivity at the stump&#xD;
&#xD;
          -  unimpaired contralateral lower extremity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  psychiatric disorder&#xD;
&#xD;
          -  cognitive restrictions&#xD;
&#xD;
          -  pregnant or breast feeding women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Agnes Sturma, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Medical University Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Agnes Sturma, MSc</last_name>
    <phone>+43140400</phone>
    <phone_ext>61098</phone_ext>
    <email>agnes.sturma@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Oskar Aszmann</last_name>
    <phone>+43140400</phone>
    <phone_ext>69860</phone_ext>
    <email>oskar.aszmann@meduniwien.ac.at</email>
  </overall_contact_backup>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 24, 2019</study_first_submitted>
  <study_first_submitted_qc>May 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2019</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Agnes Sturma</investigator_full_name>
    <investigator_title>Physical Therapist, Research Fellow</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All IPD from the mentioned outcome parameters are planned to be made available to other researchers.</ipd_description>
    <ipd_time_frame>upon publication in a scientific journal</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

